Ondansetron
- Product NDC
- 68258-7068
- 11-digit product format
- 682587068
- Labeler code
- 68258
- Product ID
- 68258-7068_212b3aaa-746d-4702-9789-8fee4e9be397
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ondansetron
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Labeler
- Dispensing Solutions, Inc.
- Application
- ANDA078152
- Marketing category
- ANDA
- Marketing start
- 2007-06-27
- Marketing end
- 0000-00-00
- Substance
- ONDANSETRON
- Active strength
- 4 mg/1
- Pharmacologic classes
- Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68258-7068-1 | Ondansetron | 10 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 10 | | 3 |
| 68258-7068-6 | Ondansetron | 6 in 1 BOTTLE | TABLET, ORALLY DISINTEGRATING | 6 | | 3 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| ONDANSETRON | ACTIVE INGREDIENT | 4AF302ESOS | ONDANSETRON (ONDANSETRON) TABLET, ORALLY DISINTEGRATING [DISPENSING SOLUTIONS, INC.] | 3 | |
| ONDANSETRON | ACTIVE MOIETY | 4AF302ESOS | ONDANSETRON (ONDANSETRON) TABLET, ORALLY DISINTEGRATING [DISPENSING SOLUTIONS, INC.] | 3 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | ONDANSETRON (ONDANSETRON) TABLET, ORALLY DISINTEGRATING [DISPENSING SOLUTIONS, INC.] | 3 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | ONDANSETRON (ONDANSETRON) TABLET, ORALLY DISINTEGRATING [DISPENSING SOLUTIONS, INC.] | 3 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | ONDANSETRON (ONDANSETRON) TABLET, ORALLY DISINTEGRATING [DISPENSING SOLUTIONS, INC.] | 3 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | ONDANSETRON (ONDANSETRON) TABLET, ORALLY DISINTEGRATING [DISPENSING SOLUTIONS, INC.] | 3 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | ONDANSETRON (ONDANSETRON) TABLET, ORALLY DISINTEGRATING [DISPENSING SOLUTIONS, INC.] | 3 | |
| SODIUM STEARYL FUMARATE | INACTIVE INGREDIENT | 7CV7WJK4UI | ONDANSETRON (ONDANSETRON) TABLET, ORALLY DISINTEGRATING [DISPENSING SOLUTIONS, INC.] | 3 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68258-7068 | ONDANSETRON (ONDANSETRON) TABLET, ORALLY DISINTEGRATING [DISPENSING SOLUTIONS, INC.] | 3 | Legacy NDC, 2 package rows | 20111108_36c80e18-671c-4612-a8e7-07962bb102e0.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 68258-7068-1 | 68258706801 | 10 in 1 BLISTER PACK | Historical |
| 68258-7068-6 | 68258706806 | 6 in 1 BOTTLE | Historical |